2019-11-06 8-K Q3-2019 EARNINGS

Company

CytomX Therapeutics, Inc.

Filed

November 7, 2019

Period of Report

November 7, 2019

Accession Number

0001564590-19-041743

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →